Biomarkers of Acute Organ Injury in Pediatric Newly Diagnosed Type 1 Diabetes
Recruiting
Observational Study
Type 1 Diabetes Mellitus
Diabetic Ketoacidosis
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 2 – 16
- Sex
- Any
- Study type
- Observational
- Participants needed
- 45 (estimated)
- Sponsor
- Aristotle University Of Thessaloniki · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Diabetic ketoacidosis (DKA) is a severe metabolic complication in children with newly diagnosed type 1 diabetes mellitus (T1DM) and may be associated with early injury of vital organs such as the kidneys and the heart. Early detection of organ dysfunction is important for identifying children at increased risk for complications.
This observational cross-sectional study aims to evaluate biomarkers…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Children aged 2-16 years
* Newly diagnosed type 1 diabetes mellitus
* Hospital admission for initial evaluation and treatment
* Presence or absence of diabetic ketoacidosis at diagnosis
* Written informed consent from parents or legal guardians
For control group:
\- Age-matc…
Contacts